TrialJournal of gastroenterology2017

Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1.

Etsuko Iio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.